Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

• Main Authors: Claus-Henning Köhne (Author), Meinolf Karthaus (Author), Laurent Mineur (Author), Josef Thaler (Author), Marc Van den Eynde (Author), Javier Gallego (Author), Reija Koukakis (Author), Marloes Berkhout (Author), Ralf-Dieter Hofheinz (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective Data from a trial of first-line panitumumab plus FOLFIRI (folinic acid, infusional 5-fluorouracil and irinotecan) in metastatic colorectal cancer were retrospectively analysed to investigate the effects of primary tumour location and early tumour shrinkage on outcomes. Methods Pat...